SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Insys Therapeutics, Inc. to Contact the Firm Before Lead Plaintiff Deadline

NEW YORK, NY --(Marketwired - February 08, 2016) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Insys Therapeutics, Inc. ("Insys" or the "Company") ( NASDAQ : INSY ) of the April 4, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the District of Arizona on behalf of all those who purchased Insys securities between March 3, 2015 and January 25, 2016 (the "Class Period"). The case, Di Donato v. Insys Therapeutics Incorporated et al, No. 2:16-cv-00302 (D. Ariz. Feb 02, 2016) was filed on February 2, 2016, and has been assigned to Judge Neil V. Wake.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that the Company was engaged in the illegal and improper off-labeling marketing of its core product, Subsys.

Specifically, the Southern Investigating Report Foundation ("SIRF") published articles on April 24, 2015 and December 3, 2015 as well as on January 25, 2016 alleging that the Company and key executives had been operating a deceptive scheme in order to bolster the illegal off-label marketing and sale of Subsys, had been pressuring employees to promote this scheme, and had not been transparent about cases of patients who had either died or suffered adverse events while being treated with Subsys.

Furthermore, on June 15, 2015, New York Times published an article that covered the guilty conviction of a Connecticut nurse who accepted more than $83,000 in kickbacks from Insys as payment for writing $1 million worth of Subsys prescriptions.

As a result of these articles, Insys' stock price dropped from $31.21 per share (adjusted for the 2:1 stock split) on April 24, 2015 to $21.58 per share on January 25, 2016, a decline of more than 30%.

Request more information now by clicking here: www.faruqilaw.com/INSY . There is no cost or obligation to you.

Take Action

If you invested in Insys securities between March 3, 2015 and January 25, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/INSY . You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com . Faruqi & Faruqi, LLP also encourages anyone with information regarding Insys' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP 685 Third Avenue, 26 th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. Email contact Telephone: (877) 247-4292 or (212) 983-9330

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 201

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Nvidia Faces SEC Probe Report and New Lawsuit Stakes

Updated Category News Views 40

Silicon Valley's favorite growth machine has stumbled into the sort of fog investors hate most: regulatory questions, leadership upheaval, and a stock-price reaction with no clean answer attached. Reports cited in the lawsuit update say the Securities and Exchange Commission has opened a civil probe into NVIDIA's investor disclosures following former CEO Jensen Huang's...

Continue Reading
PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 131

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 22

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Teciem’s New CFO Puts Financial Discipline Behind Growth

Updated Category News Views 43

A finance chief moving continents is not decorative corporate wallpaper. Teciem’s decision to appoint Jesús Rueda Molins as chief financial officer says the company wants its next growth chapter run with more than product ambition and executive slogans. It wants somebody holding the purse strings who already knows the machinery, the customers and the people making the...

Continue Reading
Radiology Staffing Gap Deepens as Imaging Demand Rises

Updated Category News Views 112

An imaging order does not mean much if nobody is available to read it, and that plain operational fact sits at the center of Medicus Healthcare Solutions' 2026 report on the radiologist shortage. The report's projected gap of 2,450 full-time-equivalent radiologists in 2027 is troubling enough. Its estimate of a 4,130 FTE shortfall by 2032 is the part that should make...

Continue Reading
SK hynix Faces Fresh DRAM Collusion Risk for Investors

Updated Category News Views 102

A Memory Market Win Can Turn Sour Fast Nothing rattles a chip story quite like the word collusion showing up beside a judge’s ruling. SK hynix had been riding a powerful memory-market narrative, but investors got a blunt reminder on November 15, 2026: a proposed U.S. class action accusing SK hynix, Samsung Electronics, and Micron of restricting DRAM supply to raise...

Continue Reading
Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 105

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 0

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 275

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading

Top 5 Most Recently Viewed Articles

Kantor & Kantor Achieves Prestigious Recognition in 2025

Updated Category News Views 347

Kantor & Kantor Honored in the Chambers 2025 Spotlight Guide Recognizing Excellence in Policyholder Advocacy and Appellate Law Kantor & Kantor, LLP has proudly received the notable distinction of being included in the Chambers 2025 Small and Medium Firm Spotlight Guide. This unique recognition is not just an accolade; it reflects the firm’s unwavering commitment to...

Continue Reading
Foxconn Industrial Internet's Strategic Offshore Debt Initiation

Updated Category News Views 144

Foxconn Industrial Internet's Strategic Financial Move Foxconn Industrial Internet Co., Ltd. (FII), part of the renowned Hon Hai Precision Industry Co. Ltd., is embarking on a significant financial strategy. The company has announced its plans to issue offshore corporate debt instruments, aiming to raise up to USD 2 billion under its existing medium-term note program....

Continue Reading
Alloy's Growth Strategy: Investing in Teams and Innovations

Updated Category News Views 278

Alloy's Commitment to Growth and Innovation Alloy, a prominent player in identity and fraud prevention solutions, is making strides in the industry as it expands its reach to over 700 clients worldwide. This varied clientele includes well-known financial institutions and fintech companies, demonstrating Alloy's growing influence and reliability. The company attributes its...

Continue Reading
Exciting Upcoming Treasury Bill Auction for Investors

Updated Category News Views 158

Details of the Upcoming Treasury Bill Auction The Government is preparing for an exciting auction of Treasury bills, specifically the RIKV 25 0219 and RIKV 25 0521 series. Investors interested in these Treasury bills should take note of the important details surrounding the auction and the investment opportunity it presents. Understanding Treasury Bills Treasury bills,...

Continue Reading
Fluor Corporation Lawsuit: Key Information for Investors

Updated Category News Views 274

Fluor Corporation Faces Class Action Lawsuit Recently, many investors have been alarmed by the news surrounding Fluor Corporation, especially those who have suffered losses exceeding $100,000. A class action lawsuit has been filed against Fluor Corporation (NYSE: FLR), focusing on allegations of miscommunication regarding the company’s financial health. Understanding...

Continue Reading